Vikas Chonira

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Protease-stable DARPins as promising oral therapeutics”.

Protease-stable DARPins as promising oral therapeutics

Protein Engineering Design and Selection(2021)10.1093/protein/gzab028

N/A

0DataRank · unranked

4 citations

Yu Zeng, Vikas Chonira, Andrea Martinez Aguirre, Mauricio Lasagna, Marko Baloh +4 more

A potent and broad neutralization of SARS-CoV-2 variants of concern by DARPins

Nature Chemical Biology(2022)10.1038/s41589-022-01193-2

N/A

0DataRank · unranked

22 citations

Young Do Kwon, Jason Gorman, James Brett Case, Zhiqiang Ku, Rudo Simeon +16 more

A Multi-Specific DARPin Potently Neutralizes Shiga Toxin 2 via Simultaneous Modulation of Both Toxin Subunits

Bioengineering(2022)10.3390/bioengineering9100511

N/A

0DataRank · unranked

7 citations

Mengqiu Jiang, Sally R. Robinson, Zeyu Peng, Vikas Chonira, Rudo Simeon +4 more

Potent and pan-neutralization of SARS-CoV-2 variants of concern by DARPins

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.05.30.493765

N/A

0DataRank · unranked

2 citations

Young Do Kwon, Jason Gorman, James Brett Case, Zhiqiang Ku, Rudo Simeon +13 more

Correction to: Protease-stable DARPins as promising oral therapeutics

Protein Engineering Design and Selection(2022)10.1093/protein/gzac003

N/A

0DataRank · unranked

0 citations

Yu Zeng, Vikas Chonira, Andrea Martinez Aguirre, Mauricio Lasagna, Marko Baloh +4 more